Concarlo Therapeutics
An exciting new biotech startup developing novel therapeutics to target ER/PR+ Her2- breast cancer. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD618—927k (Dealroom.co estimates Mar 2018.)
New York City New York (HQ)
Authorizing premium user...